BioSenic S.A. (LON:0R55)
London · Delayed Price · Currency is GBP · Price in EUR 0.0023
0.00 (0.00%)
Feb 12, 2026, 3:04 PM GMT
BioSenic Market Cap
BioSenic has a market cap or net worth of 1.36 million as of February 12, 2026. Its market cap has increased by 15.28% in one year.
Market Cap
1.36M
Enterprise Value
21.42M
Revenue
-2.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.00
Market Cap Chart
Since October 26, 2022, BioSenic's market cap has decreased from 6.15M to 1.36M, a decrease of -77.82%. That is a compound annual growth rate of -36.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.31M | -0.31% |
| Dec 31, 2025 | 1.31M | -15.69% |
| Dec 31, 2024 | 1.55M | -82.07% |
| Dec 29, 2023 | 8.67M | 225.90% |
| Dec 30, 2022 | 2.66M | -56.79% |
| Oct 26, 2022 | 6.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genflow Biosciences | 9.38M |
| OptiBiotix Health | 7.64M |
| Futura Medical | 7.57M |
| CRISM Therapeutics | 7.37M |
| Cizzle Biotechnology Holdings | 6.14M |
| Nuformix | 5.06M |
| Theracryf | 4.51M |
| ValiRx | 2.49M |